The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours

Journal of Pathology

Volumn 196, Issue 4, 2002, Pages 437-444

  Sawyer, Elinor J ^a,b   Hanby, Andrew M ^c   Rowan, Andrew J ^a   Gillett, Cheryl E ^b   Thomas, Rachel E ^c   Poulsom, Richard ^a   Lakhani, Sunil R ^d   Ellis, Ian O ^e   Ellis, Paul ^b   Tomlinson, Ian P M ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

APC; Cyclin D1; Epithelial stromal interactions; Phyllodes; Wnt; catenin

Indexed keywords

APC PROTEIN; BETA CATENIN; CYCLIN D1; MESSENGER RNA; WNT PROTEIN;

ARTICLE; CELL INTERACTION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION FUNCTION; CYSTOSARCOMA PHYLLOIDES; EPITHELIUM CELL; EXON; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCREENING TEST; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STROMA CELL;

EID: 0036207721     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1067     Document Type: Article

References (35)

1. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components
2. Clonal analysis of fibroadenoma and phyllodes tumor of the breast
3. The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes
4. Cystosarcoma phyllodes. A review of 19 cases with emphasis on the occurrence of associated breast carcinoma
5. Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue
6. Wnt5a cloning, expression, and up-regulation in human primary breast cancers
7. Beta-catenin signalling and cancer
8. Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system
9. CA-repeat polymorphism close to the adenomatous polyposis coli (APC) gene offers improved diagnostic testing for familial APC
10. Analysis of foetal expression sites of human type II DNA topoisomerase alpha and beta mRNAs by in situ hybridisation
11. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway
12. Membrane-anchored plakoglobins have multiple mechanisms of action in Wnt signaling
13. Gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin
14. Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways
15. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)
16. Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas
17. Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma
18. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas
19. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: Oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles
20. A common human skin tumour is caused by activating mutations in beta-catenin
21. Truncating somatic mutation in exon 15 of the APC gene is a rare event in human breast carcinomas
22. APC truncation and increased β-catenin levels in a human breast cancer cell line
23. Cyclin D1 in breast cancer
24. Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling in human breast cancer
25. Beta-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression
26. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling
27. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
28. Sequence variants of the axin gene in breast, colon, and other cancers: An analysis of mutations that interfere with GSK3 binding
29. Transformation by Wnt family proteins correlates with regulation of beta-catenin
30. Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma
31. Correlation of cyclin D1 mRNA levels with clinico-pathological parameters and clinical outcome in human breast carcinomas
32. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia
33. Cyclin D1 expression in ductal carcinoma in situ, atypical ductal hyperplasia and usual ductal hyperplasia: An immunohistochemical study
34. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression